Centre Hospitalier Lyon Sud, Lyon

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 1 / Phase 2	2024-05-29		NCT05580861

Clinical trials